Per ADA 2026 Standards of Care, patients with presymptomatic Type 1 DM (stage 12) may be identified by autoantibody screening before frank hyperglycemia occurs
Getting the Right Ozempic Dose Getting the right dosage is very crucial for both safety and effectiveness
The JAMA Internal Medicine meta-analysis of 76 randomized trials quantified the class-wide risk: Cholelithiasis: relative risk 1.27 across all GLP-1 RAs Cholecystitis: relative risk 1.36 Biliary disease composite: relative risk 1.55 Higher doses carried higher risk than lower doses Longer treatment duration carried higher risk than shorter duration For high-risk populations, particularly older women, close monitoring for cholecystitis and cholelithiasis during GLP-1 therapy is recommended
Glucagon-like peptide-1 (GLP-1) is a hormone thats naturally produced and released in the gut during digestion
Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, et al